SHERMAN JEFFREY W 4
4 · Xeris Biopharma Holdings, Inc. · Filed Nov 29, 2023
Insider Transaction Report
Form 4
SHERMAN JEFFREY W
Director
Transactions
- Purchase
Common Stock
2023-11-27$1.87/sh+5,400$10,098→ 5,400 total(indirect: By Trust)
Holdings
- 107,878
Common Stock
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.